Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Evolus, Inc.
EOLS · SEC Filings
website
353
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical...
Price
6.98
Market Cap
461.99 M
Float
65.37 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about EOLS
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Evolus, Inc.
EOLS · SEC Filings
65.37 M
Float
6.98
Price
461.99 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 4, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 4, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 3, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 5, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 5, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Evolus Reports Third Quarter 2026 Financial Results with 13% Year-Over-Year Revenue Growth
Nov 4, 2026
8-K
Evolus Reports Strong Second Quarter 2026 Financial Results and Raises Full-Year 2026 Outlook
Aug 5, 2026
8-K
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Aug 4, 2026
8-K
Evolus Enters Exclusive Agreement with IBSA to Commercialize Profhilo® in the U.S.
Jul 8, 2026
8-K
Evolus, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 12, 2026
8-K
Evolus Reports First Quarter 2026 Financial Results and Reaffirms Full-Year Outlook
May 4, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
SHELF OFFERING | Shares amount: 3,554,000 | Share price: $14.07 | Offering amount: $50,004,780.00
Mar 11, 2024
424B5
ATM | Offering amount: $50,000,000
Jun 9, 2023
424B5
15,700,376 Shares-
Apr 22, 2021
424B5
15,700,376 Shares-
Apr 21, 2021
424B5
15,700,376 Shares-
Mar 26, 2021
424B5
5,217,000 Shares
Nov 7, 2019
Registrations
TYPE
HEADLINE
FILED AT
S-3
June 2026 SHELF
Jun 5, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 3, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 4, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 6, 2024
S-8
Registration
Mar 7, 2024
S-8
Registration
Oct 6, 2023
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 25, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 26, 2024
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
NEW
Soleus Capital Master Fund, L.P. (Filed by)
Nov 9, 2026
4
MOATAZEDI DAVID (Reporting)
Sep 4, 2026
144
Form 144 - Report of proposed sale of securities
Sep 2, 2026
SCHEDULE 13G
Soleus Capital Master Fund, L.P. (Filed by)
Aug 31, 2026
S-3
Form S-3 - Registration statement under Securities Act of 1933
Jun 5, 2026
SCHEDULE 13G/A
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 26, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
